A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive or refractory CNS tumors: A pediatric brain tumor consortium (PBTC) study Meeting Abstract
| Authors: | Van Mater, D.; Gururangan, S.; Leary, S.; Becher, O.; Phillips, J.; Huang, J.; Campagne, O.; Poussaint, T.; Goldman, S.; Baxter, P.; Dhall, G.; Robinson, G.; DeWire-Schottmiller, M.; Hwang, E.; Stewart, C.; Onar-Thomas, A.; Dunkel, I.; Fouladi, M. |
| Abstract Title: | A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive or refractory CNS tumors: A pediatric brain tumor consortium (PBTC) study |
| Meeting Title: | 19th International Symposium on Pediatric Neuro-Oncology (ISPNO 2020) |
| Journal Title: | Neuro-Oncology |
| Volume: | 22 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2020 Dec 13-16 |
| Meeting Location: | Karuizawa, Japan |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-12-01 |
| Start Page: | iii304 |
| Language: | English |
| ACCESSION: | WOS:000606080100130 |
| PROVIDER: | wos |
| DOI: | 10.1093/neuonc/noaa222.129 |
| Notes: | Meeting Abstract: EPCT-05 -- Source: Wos |
